To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00323817

Enrollment

282

Registered

2006-05-10

Start date

2006-04-30

Completion date

2009-10-31

Last updated

2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Brief summary

To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia

Interventions

DRUGZ-338

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Subjects presenting diagnosis of FD as defined by the Rome II * Subjects presenting postprandial fullness and/or Early satiety should be the most bothersome symptom

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Global subject Outcome Assessment	12 month

Secondary

Measure	Time frame
Individual symptom	12 month

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026